Line Hyltoft Kristensen

Line Hyltoft Kristensen is an accomplished scientist with extensive experience in drug device and combination products, as well as bio-process development. Holding the position of Senior Scientist at LEO Pharma, Line has also served as a Principal Scientist and Senior Scientist at Dragonfly Therapeutics, Inc., and held temporary Senior Scientist roles at Synklino. Prior experience includes working as a Downstream Scientist at Symphogen and as an International PostDoc in the Haemophilia Biology group at Novo Nordisk A/S in collaboration with the Hans Brandstetter group at the University of Salzburg. Line earned a Ph.D. in Structural Biology and Protein Chemistry and a Cand. Scient in Biochemistry from the University of Copenhagen.